HomeComparePFDR vs JNJ

PFDR vs JNJ: Dividend Comparison 2026

PFDR yields 23.31% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PFDR wins by $69.3K in total portfolio value
10 years
PFDR
PFDR
● Live price
23.31%
Share price
$8.58
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$89.3K
Annual income
$9,457.75
Full PFDR calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — PFDR vs JNJ

📍 PFDR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPFDRJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PFDR + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PFDR pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PFDR
Annual income on $10K today (after 15% tax)
$1,981.35/yr
After 10yr DRIP, annual income (after tax)
$8,039.09/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, PFDR beats the other by $7,335.47/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PFDR + JNJ for your $10,000?

PFDR: 50%JNJ: 50%
100% JNJ50/50100% PFDR
Portfolio after 10yr
$54.6K
Annual income
$5,142.77/yr
Blended yield
9.41%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

PFDR
No analyst data
Altman Z
2.8
Piotroski
5/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PFDR buys
0
JNJ buys
0
No recent congressional trades found for PFDR or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPFDRJNJ
Forward yield23.31%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$89.3K$20.0K
Annual income after 10y$9,457.75$827.78
Total dividends collected$54.7K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PFDR vs JNJ ($10,000, DRIP)

YearPFDR PortfolioPFDR Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$13,031$2,331.00$10,676$355.77+$2.4KPFDR
2$16,782$2,838.81$11,407$389.39+$5.4KPFDR
3$21,374$3,416.79$12,198$426.53+$9.2KPFDR
4$26,937$4,066.94$13,056$467.62+$13.9KPFDR
5$33,612$4,790.16$13,987$513.12+$19.6KPFDR
6$41,551$5,586.28$14,998$563.56+$26.6KPFDR
7$50,914$6,453.96$16,098$619.52+$34.8KPFDR
8$61,869$7,390.84$17,295$681.69+$44.6KPFDR
9$74,593$8,393.53$18,599$750.82+$56.0KPFDR
10$89,272$9,457.75$20,022$827.78+$69.3KPFDR

PFDR vs JNJ: Complete Analysis 2026

PFDRStock

Pathfinder Acquisition Corporation does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the technology or technology-enabled sectors. The company was incorporated in 2020 and is based in Palo Alto, California.

Full PFDR Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this PFDR vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PFDR vs SCHDPFDR vs JEPIPFDR vs OPFDR vs KOPFDR vs MAINPFDR vs ABBVPFDR vs MRKPFDR vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.